|
Market Closed -
Japan Exchange
02:30:00 2026-08-13 EDT
|
5-day change | 1st Jan Change | ||
| 2,417.50 JPY | +0.06% |
|
+3.40% | +11.28% |
| 07-31 | Ono Pharmaceutical's Profit Rises 37% in Fiscal Q1 | MT |
| 07-30 | Ono Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
| Market Cap | 1,135B 7.13B 6.18B 5.79B 5.28B 9.92B 680B 10.08B 68.07B 26.61B 340B 26.77B 26.19B | P/E 2027 * |
15.9x | P/E 2028 * | 18.1x |
|---|---|---|---|---|---|
| Enterprise Value | 935B 5.87B 5.09B 4.77B 4.35B 8.17B 560B 8.3B 56.05B 21.91B 280B 22.04B 21.56B | EV / Sales 2027 * |
2.06x | EV / Sales 2028 * | 2x |
| Free-Float |
80.98% | Yield 2027 * |
3.24% | Yield 2028 * | 3.21% |
Last Transcript: Ono Pharmaceutical Co., Ltd.
| 1 day | +0.06% | ||
| 1 week | +3.40% | ||
| Current month | +1.41% | ||
| 1 month | +0.71% | ||
| 3 months | -5.31% | ||
| 6 months | -4.69% | ||
| Current year | +11.28% |
| 1 week | 2,332.5 |  | 2,436 |
| 1 month | 2,264.5 | | 2,514.5 |
| Current year | 2,114.5 | | 2,674.5 |
| 1 year | 1,596 | | 2,674.5 |
| 3 years | 1,474 | | 2,966.5 |
| 5 years | 1,474 | | 3,990 |
| 10 years | 1,474 | | 3,990 |
| Manager | Title | Age | Since |
|---|---|---|---|
Gyo Sagara
CEO | Chief Executive Officer | 67 | 2024-03-31 |
Masaki Ito
DFI | Director of Finance/CFO | - | 2026-03-31 |
Toichi Takino
PSD | President | 57 | 2024-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Gyo Sagara
CHM | Chairman | 67 | 2024-03-31 |
Toichi Takino
BRD | Director/Board Member | 57 | 2020-05-31 |
Masao Nomura
BRD | Director/Board Member | 77 | 2018-06-25 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.06% | +3.40% | +39.10% | -12.90% | 7.13B | |
| -0.62% | -0.97% | +17.82% | +70.33% | 48.9B | |
| +1.51% | +2.18% | +55.42% | +124.54% | 40.42B | |
| -3.13% | +5.35% | +18.08% | +81.92% | 12.6B | |
| -0.29% | -1.23% | -6.55% | +18.06% | 12.39B | |
| -1.35% | -0.76% | +30.40% | +135.91% | 9.07B | |
| -1.15% | +6.62% | +22.78% | +38.49% | 7.53B | |
| +1.31% | +2.20% | +14.33% | +190.85% | 6.78B | |
| -0.87% | +2.74% | -25.38% | +28.51% | 5.83B | |
| +2.08% | +4.16% | +35.29% | +107.90% | 4.64B | |
| Average | -0.24% | +3.28% | +20.13% | +78.36% | 15.53B | |
| Weighted average by Cap. | -0.12% | +2.57% | +26.38% | +84.49% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 455B 2.86B 2.47B 2.32B 2.11B 3.97B 272B 4.04B 27.26B 10.66B 136B 10.72B 10.49B | 445B 2.79B 2.42B 2.27B 2.07B 3.89B 266B 3.95B 26.66B 10.42B 133B 10.48B 10.25B |
| Net income | 71.42B 448M 389M 364M 332M 624M 42.77B 634M 4.28B 1.67B 21.42B 1.68B 1.65B | 62.78B 394M 342M 320M 292M 549M 37.6B 557M 3.76B 1.47B 18.83B 1.48B 1.45B |
| Net Debt | -200B -1.26B -1.09B -1.02B -932M -1.75B -120B -1.78B -12.02B -4.7B -60.1B -4.73B -4.62B | -248B -1.56B -1.35B -1.27B -1.15B -2.17B -149B -2.2B -14.88B -5.82B -74.43B -5.85B -5.72B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-13 | JP¥2,417.50 | +0.06% | 1,481,200 |
| 26-08-12 | JP¥2,416.00 | -0.12% | 1,622,100 |
| 26-08-10 | JP¥2,419.00 | +1.62% | 1,335,600 |
| 26-08-07 | JP¥2,380.50 | +1.82% | 1,307,700 |
| 26-08-06 | JP¥2,338.00 | +1.61% | 1,513,200 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4528 Stock
Select your edition
All financial news and data tailored to specific country editions
